Hudson Bay Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-90,100
Closed -$7.85M 1514
2025
Q2
$7.85M Sell
90,100
-34,700
-28% -$2.94M 0.03% 418
2025
Q1
$11.2M Buy
+124,800
New +$11.2M 0.03% 370
2017
Q3
Sell
-100,000
Closed -$8.88M 473
2017
Q2
$8.88M Sell
100,000
-16,600
-14% -$1.4M 0.18% 120
2017
Q1
$9.39M Buy
+116,600
New +$9.11M 0.13% 169

Other funds holding MDT

Hudson Bay Capital Management's MDT Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Medtronic (MDT) stake by 33% in Q1 2026, selling an estimated $1.44M and leaving 30,000 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #695.

Hudson Bay Capital Management first reported a position in MDT in Q3 2014 and has held it in 12 quarters since. The position peaked at $21.7M in Q3 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hudson Bay Capital Management held 30,000 shares of Medtronic worth $2.6M as of Q1 2026.
  • Hudson Bay Capital Management sold 15,000 Medtronic shares in Q1 2026, an estimated $1.44M.
  • Medtronic made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #695 holding.
  • Hudson Bay Capital Management first reported a position in Medtronic in Q3 2014 and has held it in 12 quarters since.
  • Hudson Bay Capital Management's Medtronic position peaked at $21.7M in Q3 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.